Rajeev Singh Raghuvanshi takes charge as new Drugs Controller General of India
New Delhi: Rajeev Singh Raghuvanshi has been appointed as the new Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO) by the Appointment Committee of the Cabinet led by the Prime Minister Narendra Modi on Wednesday.
Raghuvanshi will be replacing PBN Prasad, who was given an interim charge of DCGI. The Union Health Ministry had appointed P B N Prasad as interim DCGI on February 16 till February 28.
Prasad had replaced V G Somani, whose three-year tenure had expired in August 2022. He was, however, not given more extension beyond the two he received in August and November in the year 2022.
Also Read: Dr PBN Prasad To Hold Charge As DCGI On Temporary Basis
Lately, the Union Government, in an official statement said, “The Appointment Committee of the Cabinet has approved the proposal for appointment of Dr Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission to the post of Drugs Controller (India), Central Drugs Standard Control Organization (CDSCO) in level 14 of the Pay Matrix, on short term contract basis, with effect from the date of his assumption of charge of the post till his attainting the age of superannuation on 28.2.2025, or until further orders, whichever is earlier."
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.